Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomes
Titel:
Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomes
Auteur:
Hoffman, Eric P. Riddle, Valerie Siegler, Maxime A. Dickerson, Daniel Backonja, Miroslav Kramer, William G. Nagaraju, Kanneboyina Gordish-Dressman, Heather Damsker, Jesse M. McCall, John M.